Live feed
Filing
SC 13G
SC 13G0000899140-22-000619·Achilles Therapeutics plc
Schedule 13G ownership disclosure
ACHILLES THERAPEUTICS PLC
Security class unavailable · CUSIP: 00449L102
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,079,965
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-22-000619
- Form type
- SC 13G
- Filer
- Achilles Therapeutics plc
- CIK
- CIK 1830749
- Filed
- Jul 25, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership